Overview
SYRE market data
Price History
SYRE price chart · 1M
- O
- 91.96
- H
- 92.40
- L
- 90.67
- C
- 90.67
- Vol
- 40,472.00
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $91.96
- Previous Close
- $91.03
- Day High
- $92.40
- Day Low
- $90.67
- 52 Week High
- $110.14
- 52 Week Low
- $64.75
- 7 Day Return
- +4.17%
- 30 Day Return
- -13.37%
- 90 Day Return
- +2.61%
- 1 Year Return
- +36.08%
- Daily Notional Volume
- $3.7M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.42 Diluted earnings per share over the trailing twelve months.
- Beta
- 3.21 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -22,158.5% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $14.51 – $110.18 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $8B · P/B 3.55 · P/S 6,494.75.
Company News
10 captured
Spyre's SPY003 Met Its Primary EndpointBenzinga ·
8-K filing — Spyre Therapeutics, Inc. (SYRE)SEC EDGAR ·
Spyre Therapeutics Says Rheumatoid Arthritis Program Misses Internal Benchmark, Stock TumblesBenzinga ·